Human evidence record · GHRP-2
GHRP-2 endocrine response in healthy men
GHRP-2 increased GH, ACTH and prolactin; vasopressin was not stimulated.
Quick read
Human evidence record
What this study tells us
This was a human pharmacology or physiology study. It can show what the compound does to measured biological signals, but it may not establish a meaningful clinical benefit.
Who was studied?
Healthy men
How many?
n=10
What happened?
GHRP-2 increased GH, ACTH and prolactin; vasopressin was not stimulated.
What stops us overclaiming?
Tiny short-term physiology study; not a therapeutic efficacy trial.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
GHRP-2 increased GH, ACTH and prolactin; vasopressin was not stimulated.
Study details
Study designSmall controlled physiology study
PopulationHealthy men
Sample size10
RouteIntravenous
Regimen / exposure100 microg bolus
Duration60 minutes
ComparatorFasting/non-fasting conditions
Primary endpoint / questionGH, ACTH, prolactin and vasopressin responses
Safety resultDemonstrates non-GH pituitary/endocrine activity relevant to safety interpretation.
Key limitationsTiny short-term physiology study; not a therapeutic efficacy trial.
Registry / identifierPMID 19907099